Utah Retirement Systems Alnylam Pharmaceuticals, Inc. Transaction History

Utah Retirement Systems

$8.31 Billion
Q2 2024

A detailed history of Utah Retirement Systems transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 20,725 shares of ALNY stock, worth $5.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

20,725

Previous 21,525 3.72%

Holding current value

$5.7 Million

Previous $3.22 Million 56.59%

% of portfolio

0.06%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $114,648 - $197,600	-800 Reduced 3.72%	20,725 $5.04 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $14,651 - $19,820	100 Added 0.47%	21,525 $3.22 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $15,141 - $19,657	100 Added 0.47%	21,425 $4.1 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $17,077 - $21,165	100 Added 0.47%	21,325 $3.78 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $111,006 - $127,230	-600 Reduced 2.75%	21,225 $4.03 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $9,863 - $12,718	54 Added 0.25%	21,825 $4.37 Million
Q4 2022 Feb 15, 2023	BUY	$185.53 - $241.31 $36,920 - $48,020	199 Added 0.92%	21,771 $5.17 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $27,708 - $46,400	200 Added 0.94%	21,572 $4.32 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $12,718 - $17,391	-100 Reduced 0.47%	21,372 $3.49 Million
Q3 2021 Nov 16, 2021	SELL	$169.75 - $207.73 $135,800 - $166,184	-800 Reduced 3.59%	21,472 $4.06 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $12,863 - $17,689	100 Added 0.45%	22,272 $3.78 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $126,830 - $175,690	-1,000 Reduced 4.32%	22,172 $3.13 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $122,970 - $147,000	1,000 Added 4.51%	23,172 $3.01 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $48,476 - $66,196	400 Added 1.84%	22,172 $3.23 Million
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $166,736 - $250,304	1,600 Added 7.93%	21,772 $3.23 Million
Q4 2019 Feb 12, 2020	BUY	$74.51 - $124.23 $7,451 - $12,423	100 Added 0.5%	20,172 $2.32 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $35,450 - $43,910	500 Added 2.55%	20,072 $1.61 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $115,847 - $163,217	1,759 Added 9.87%	19,572 $1.42 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $80,981 - $104,009	1,113 Added 6.66%	17,813 $1.67 Million
Q4 2018 Feb 08, 2019	BUY	$62.67 - $88.33 $6,267 - $8,833	100 Added 0.6%	16,700 $1.22 Million
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $8,752 - $12,267	100 Added 0.61%	16,600 $1.45 Million
Q2 2018 Aug 10, 2018	BUY	$88.31 - $107.8 $26,493 - $32,340	300 Added 1.85%	16,500 $1.63 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $23,184 - $29,708	200 Added 1.25%	16,200 $1.93 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $160,286 - $195,972	1,400 Added 9.59%	16,000 $2.03 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $1.06 Million - $1.73 Million	14,600	14,600 $1.72 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Alnylam Pharmaceuticals, Inc. Transaction History